Case Name (Date)

Plowden et al. v. Similasan Corp.
23-cv-2511, D. Colo.
(Sept. 2023)


Product/Service

Similasan Eye Relief products


Allegations

Marketing products as able to relieve various eye issues – including watery eyes, grittiness, redness, strain, and burning – when the company does not have FDA approval to make such drug claims and has not shown that the products are “generally recognized as safe and effective”


Status

Settled
(Motion for preliminary approval filed)



The Latest

Filters

Relivira

Ad Alert

Relivira

Underwear seller strips a number of marketing claims after a TINA.org inquiry.


Show More